PL2918593T3 - Polimorfy benfotiaminowe, sposób ich otrzymywania i zastosowanie - Google Patents

Polimorfy benfotiaminowe, sposób ich otrzymywania i zastosowanie

Info

Publication number
PL2918593T3
PL2918593T3 PL12886858T PL12886858T PL2918593T3 PL 2918593 T3 PL2918593 T3 PL 2918593T3 PL 12886858 T PL12886858 T PL 12886858T PL 12886858 T PL12886858 T PL 12886858T PL 2918593 T3 PL2918593 T3 PL 2918593T3
Authority
PL
Poland
Prior art keywords
benfotiamine
polymorphs
preparation
benfotiamine polymorphs
Prior art date
Application number
PL12886858T
Other languages
English (en)
Inventor
Chunjiu Zhong
Yinhua He
Xuefeng Mei
Original Assignee
Shanghai Ri Xin Biotechnology Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Ri Xin Biotechnology Co., Ltd. filed Critical Shanghai Ri Xin Biotechnology Co., Ltd.
Publication of PL2918593T3 publication Critical patent/PL2918593T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/6512Six-membered rings having the nitrogen atoms in positions 1 and 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
PL12886858T 2012-10-17 2012-10-31 Polimorfy benfotiaminowe, sposób ich otrzymywania i zastosowanie PL2918593T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201210395556.6A CN103113405B (zh) 2012-10-17 2012-10-17 苯磷硫胺多晶型体、制备方法及其应用
PCT/CN2012/083898 WO2014059702A1 (zh) 2012-10-17 2012-10-31 苯磷硫胺多晶型体、制备方法及其应用
EP12886858.5A EP2918593B1 (en) 2012-10-17 2012-10-31 Benfotiamine polymorphs, preparation method and use thereof

Publications (1)

Publication Number Publication Date
PL2918593T3 true PL2918593T3 (pl) 2018-03-30

Family

ID=48411826

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12886858T PL2918593T3 (pl) 2012-10-17 2012-10-31 Polimorfy benfotiaminowe, sposób ich otrzymywania i zastosowanie

Country Status (8)

Country Link
US (2) US9718846B1 (pl)
EP (1) EP2918593B1 (pl)
JP (1) JP6392766B2 (pl)
CN (1) CN103113405B (pl)
ES (1) ES2649412T3 (pl)
PL (1) PL2918593T3 (pl)
PT (1) PT2918593T (pl)
WO (1) WO2014059702A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103724374B (zh) * 2014-01-08 2016-01-27 珠海金鸿药业股份有限公司 一种苯磷硫胺化合物及制备方法及其含有该化合物的药物组合物
CN104122280B (zh) * 2014-08-13 2017-03-22 北京默加农生物技术发展有限公司 一种以双环铂为有效成分的药物的检测方法
CN109111478B (zh) * 2017-06-26 2021-02-26 上海日馨生物科技有限公司 苯磷硫胺衍生物、制备方法及其药物组合物
KR102294721B1 (ko) * 2018-09-28 2021-08-31 경북대학교 산학협력단 티아민 유도체를 포함하는 고코르티솔증 예방 또는 치료용 조성물
CN111233925B (zh) * 2018-11-28 2021-03-26 上海日馨生物科技有限公司 硫胺类化合物、制备方法及其药物组合物
US10947258B1 (en) 2019-08-23 2021-03-16 Shanghai Rixin Biotechnology Co., Ltd. Benfotiamine derivatives, method for preparing the same and pharmaceutical composition comprising the same
EP3981407A1 (de) * 2020-10-07 2022-04-13 WÖRWAG Pharma GmbH & Co.KG Biofaktoren zur behandlung und prophylaxe von demenz
WO2023088457A1 (zh) * 2021-11-22 2023-05-25 上海日馨医药科技股份有限公司 苯磷硫胺衍生物的固体形式及其制备方法和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3064000A (en) 1959-04-14 1962-11-13 Sankyo Kabushiki Kaisha S-benzoylthiamine o-monophosphate and a process for preparing the same
GB896089A (en) * 1959-04-14 1962-05-09 Sankyo Kabushiki Kaisha Derivatives of thiamine and their production
DE1130811B (de) 1959-04-14 1962-06-07 Sankyo Kabushiki Kaisha Verfahren zur Herstellung eines Acylierungsproduktes von Vitamin-B-orthophosphorsaeureester und Salzen davon
JP4091142B2 (ja) 1996-06-03 2008-05-28 武田薬品工業株式会社 医薬組成物
JP2006008576A (ja) 2004-06-25 2006-01-12 Kosei Tanaka ヘキサミン生合成経路活性化抑制剤
MX2007010964A (es) * 2005-03-08 2007-09-19 Wyeth Corp Formas cristalinas de 2-(3-fluoro-4-hidroxifenil)-7-vinil-1,3- benzoxazol-5-ol y su uso como moduladores del receptor estrogenico.
CN103951583B (zh) * 2006-12-06 2016-01-06 科内图斯医药公司 一种抑制剂的结晶形式
JP4585610B2 (ja) * 2007-01-22 2010-11-24 ファイザー・プロダクツ・インク 治療用化合物のトシル酸塩およびその医薬組成物

Also Published As

Publication number Publication date
EP2918593A4 (en) 2016-08-24
JP6392766B2 (ja) 2018-09-19
US9718846B1 (en) 2017-08-01
JP2015534953A (ja) 2015-12-07
EP2918593A1 (en) 2015-09-16
CN103113405B (zh) 2016-03-02
EP2918593B1 (en) 2017-10-18
USRE49935E1 (en) 2024-04-23
CN103113405A (zh) 2013-05-22
WO2014059702A1 (zh) 2014-04-24
ES2649412T3 (es) 2018-01-11
PT2918593T (pt) 2018-01-11

Similar Documents

Publication Publication Date Title
GB201223172D0 (en) Method
EP2907501A4 (en) BEAUTY CARE PROCESS
GB201212937D0 (en) Method
EP2907500A4 (en) BEAUTY CARE PROCESS
GB201212932D0 (en) Method
PL2817775T3 (pl) Sposób pomiaru oglądalności
GB201212934D0 (en) Method
GB201213636D0 (en) Method
GB201222693D0 (en) Novel method
PT2918593T (pt) Polimorfos de benfotiamina, seu método de preparação e utilização
GB201210858D0 (en) Method
SG11201408326TA (en) Preparation method for perfluoro-2-methyl-3-pentanone and intermediate
SG11201407032WA (en) Method
PL2809816T3 (pl) Sposób ekspresji
EP2805954A4 (en) 7-SUBSTITUTED HANFANGICHIN B DERIVATIVE AND MANUFACTURING METHOD AND USE THEREOF
GB201218570D0 (en) Method
GB201202198D0 (en) Method
PL2915582T3 (pl) Złożony tlenek, sposób jego wytwarzania i jego zastosowanie
GB201223316D0 (en) Method
GB201214029D0 (en) method
GB201211393D0 (en) Method
GB201222737D0 (en) Method
EP2869895A4 (en) SOUNDING METHOD
GB201217688D0 (en) Method
GB201210147D0 (en) Method